Literature DB >> 15598811

Ly49Q defines 2 pDC subsets in mice.

Yumiko Kamogawa-Schifter1, Jun Ohkawa, Sahori Namiki, Naoko Arai, Ken-Ichi Arai, Yongjun Liu.   

Abstract

Plasmacytoid dendritic cells (pDCs) play an important primary role for antiviral innate immunity by rapidly producing large amounts of type 1 interferon (IFN) upon viral infection. To study pDC biology, we generated a monoclonal antibody, termed 2E6, that recognizes pDCs. Molecular cloning of a cDNA encoding the 2E6 antigen revealed that it is a type II C-type lectin, Ly49Q, that consists of 247 amino acids with high homology to the natural killer (NK) receptor family Ly49, with an immunoreceptor tyrosine-based inhibitory motif in the cytoplasmic domain. Ly49Q is expressed on pDCs but not on NK cells or myeloid dendritic cells. B220+, CD11c+, CD11b- pDCs in bone marrow were divided into Ly49Q+ and Ly49Q- subsets. While both subsets produced IFN-alpha upon cytosine-phosphate-guanosine (CpG) and herpes simplex virus stimulation, Ly49Q- pDCs responded poorly to influenza virus. In addition, Ly49Q- pDCs produced inflammatory cytokines such as interleukin 6 (IL-6), IL-12, and tumor necrosis factor alpha (TNF-alpha) upon stimulation at lower levels than those produced by Ly49Q+ pDCs. In contrast to bone marrow, Ly49Q+ pDCs were only found in peripheral blood, lymph nodes, and spleen. These results indicate that Ly49Q is a specific marker for peripheral pDCs and that expression of Ly49Q defines 2 subsets of pDCs in bone marrow.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598811     DOI: 10.1182/blood-2004-09-3388

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Ikaros is required for plasmacytoid dendritic cell differentiation.

Authors:  David Allman; Marc Dalod; Carine Asselin-Paturel; Thomas Delale; Scott H Robbins; Giorgio Trinchieri; Christine A Biron; Philippe Kastner; Susan Chan
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

2.  Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification.

Authors:  Lucja T Grajkowska; Michele Ceribelli; Colleen M Lau; Margaret E Warren; Ioanna Tiniakou; Sandra Nakandakari Higa; Anna Bunin; Hans Haecker; Leonid A Mirny; Louis M Staudt; Boris Reizis
Journal:  Immunity       Date:  2016-12-13       Impact factor: 31.745

Review 3.  Harnessing human dendritic cell subsets for medicine.

Authors:  Hideki Ueno; Nathalie Schmitt; Eynav Klechevsky; Alexander Pedroza-Gonzalez; Toshimichi Matsui; Gerard Zurawski; SangKon Oh; Joseph Fay; Virginia Pascual; Jacques Banchereau; Karolina Palucka
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

Review 4.  Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells.

Authors:  Wei Cao; Laura Bover
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

Review 5.  Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

Review 6.  The multifaceted biology of plasmacytoid dendritic cells.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Nat Rev Immunol       Date:  2015-07-10       Impact factor: 53.106

7.  Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation.

Authors:  Jian-Ming Li; Lauren T Southerland; Ying Lu; Kataryna A Darlak; Cynthia R Giver; Douglas W McMillin; Wayne A C Harris; David L Jaye; Edmund K Waller
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions.

Authors:  Toshimichi Matsui; John E Connolly; Mark Michnevitz; Damien Chaussabel; Chun-I Yu; Casey Glaser; Sasha Tindle; Marc Pypaert; Heidi Freitas; Bernard Piqueras; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

9.  In vivo conversion of BM plasmacytoid DC into CD11b+ conventional DC during virus infection.

Authors:  Li-Ying Liou; Amanda L Blasius; Megan J Welch; Marco Colonna; Michael B A Oldstone; Elina I Zuniga
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

Review 10.  Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.

Authors:  Jorge Schettini; Pinku Mukherjee
Journal:  Clin Dev Immunol       Date:  2009-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.